Prospective Study on Asthma Control (PRISMA)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01110460 |
|
Recruitment Status
:
Completed
First Posted
: April 26, 2010
Last Update Posted
: February 1, 2011
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Accordingly, the new update of the Global Initiative for Asthma (GINA) guidelines 2006 is based on the control of the disease and attempts to quantify and graduate the level of control by using a classification of asthmatic subjects into controlled,partly controlled and uncontrolled groups.
Achieving and maintaining optimal asthma control is a major goal of asthma management. Although the results of clinical trials advocate that asthma control can be reached in most patients, there is evidence that many subjects with asthma have poorly controlled disease and that there is a significant gap between the treatment goals and the current level of asthma control achieved in the general population.
The aim of this study is to assess the prevalence of uncontrolled and partly controlled asthma in Italy using a patient-based tool such as Asthma Control Test.
| Condition or disease |
|---|
| Asthma |
| Study Type : | Observational |
| Actual Enrollment : | 2875 participants |
| Observational Model: | Cohort |
| Time Perspective: | Prospective |
| Official Title: | Cross-sectional and Prospective Observational Study Aimed to Assess the Prevalence of Uncontrolled and Partially Controlled Asthmatics in Italy and the Prevalence of Uncontrolled/Partially Controlled Patients Achieved Asthma Control After 12 Months |
| Study Start Date : | January 2009 |
| Actual Primary Completion Date : | October 2009 |
| Actual Study Completion Date : | November 2010 |
- Asthma control test score [ Time Frame: 3 months ]
- EuroQoL test score [ Time Frame: 3 months ]
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
Inclusion Criteria:
- Written informed consent obtained
- Male or female patients with asthma diagnosis (at least 6 months)
- ability to understand and fill in questionaires
Exclusion Criteria:
- Patients included in a clinical trial within the last 12 weeks
- Patients with serious illnesses
- Pregnant women
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01110460
| Study Director: | Claudio Terzano | Policlinico Umberto I Roma |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Gabriele Nicolini, Chiesi Farmaceutici |
| ClinicalTrials.gov Identifier: | NCT01110460 History of Changes |
| Other Study ID Numbers: |
PRISMA |
| First Posted: | April 26, 2010 Key Record Dates |
| Last Update Posted: | February 1, 2011 |
| Last Verified: | January 2011 |
Additional relevant MeSH terms:
|
Asthma Bronchial Diseases Respiratory Tract Diseases Lung Diseases, Obstructive Lung Diseases |
Respiratory Hypersensitivity Hypersensitivity, Immediate Hypersensitivity Immune System Diseases |